A Fib Clinic of the Future Using KardiaPro Platform for Chronic Care of Patients With AF After Ablation Procedure

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 27, 2018

Primary Completion Date

February 21, 2020

Study Completion Date

August 15, 2020

Conditions
Atrial Fibrillation
Interventions
DEVICE

Kardia Monitoring

Kardia Mobile is an FDA approved device that allows one lead ECG recording for 30 seconds using the patient's smart phone. The device has a built-in algorithm that detects AF. KardiaPro is a secure platform that allows the physician to access the patient's recording at any time. The platform can also be programmed to send a notification to the healthcare provider if AF is detected by the software.

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AliveCor

INDUSTRY

lead

The Cleveland Clinic

OTHER